Press Room

Lawmakers asked to reduce barriers to care and reduce prescription related costs

Today, the Prostate-Specific Antigen Screening for High-risk Insured Men (PSA Screening for HIM) Act was introduced in the United States House of Representatives by Representatives Neal Dunn, M.D. (R-FL) and Yvette Clarke (D-NY) with Representatives Greg Murphy (R-NC) and Troy Carter (D-LA) as cosponsors.

Bipartisan legislation that would remove financial barriers to prostate cancer screening was introduced today in the U.S. Senate. Sponsored by Senators John Boozman (R-AR) and Cory Booker (D-NJ), the Prostate-Specific Antigen Screening for High-risk Insured Men (PSA Screening for HIM) Act would waive cost-sharing requirements such as deductibles, copayments and coinsurance, for prostate cancer screening tests for men with the highest risk of prostate cancer, including Black men and those with a family history of the disease.

Washington, D.C. – Today, patient groups representing millions of individuals with serious diseases and health conditions submitted an amicus curiae (friend of the court) brief urging the U.S. Court of Appeals for the Eighth Circuit to uphold insurance coverage eligibility to Deferred Action for Childhood Arrivals (DACA) recipients, as permitted by the Department of Health and Human Services (HHS) Final Rule issued in May 2024.

PROVIDENCE – December 28, 2024 – Starting the first of the year, menthol flavored e-cigarette products will still be on store shelves across Rhode Island.

Public health groups are applauding the U.S. Court of Appeals for the Fifth Circuit for upholding the non-discrimination provision of the Affordable Care Act (ACA) in the case of Neese v. Becerra. The court vacated a lower court ruling based on the plaintiffs’ lack of standing in the case, which challenged protections in the ACA for Lesbian, Gay, Bisexual, Transgender and Queer (LGBTQ+) patients receiving health care services.

On December 9, the U.S. District Court for the District of North Dakota granted a preliminary injunction in the case of Kansas v. United States. This decision temporarily blocks the Final Rule issued by the Department of Health and Human Services (HHS), which expands insurance coverage eligibility to Deferred Action for Childhood Arrivals (DACA) recipients in 19 states. 

Washington, D.C. – October 2, 2024 – Today, patient groups representing millions of individuals with serious diseases and health conditions filed an amicus curiae (friend of the court) brief strongly urging the U.S. District Court for the District of North Dakota to deny a motion for a stay and preliminary injunction in the case of Kansas v. United States of America.

The U.S. House of Representatives and the U.S. Senate introduced the Health Equity and Accountability Act (HEAA) of 2024, which provides a comprehensive set of strategic policy solutions designed to enhance the health and well-being of underserved and marginalized communities.

Federal legislation that would make it easier for all cancer patients to participate in clinical trials was introduced today in the House. Sponsored by Reps. Raul Ruiz (D-Calif.) and Larry Bucshon (R-Ind.), the Clinical Trial Modernization Act is bipartisan legislation that would increase access to clinical trials by helping remove cost and geographic barriers to patient participation.